Pozen (Nasdaq: POZN) has emerged the victor in one of two lawsuits filed against the company following rejection of a proposed drug by the FDA.

A consolidated shareholder lawsuit filed in Superior Court of Orange County in North Carolina was dismissed “with prejudice”, Pozen said in a statement.

A class action suit filed in U.S. District Court in North Carolina continues, Pozen added.

Pozen: www.Pozen.com